Colony-stimulating factors in parasitic diseases.
Reed
S G
SG
Seattle Biomedical Research Institute, Washington 98109-1651.
D000818:Animals; D002478:Cells, Cultured; D014355:Chagas Disease / Q000628:therapy*; D003115:Colony-Stimulating Factors / Q000627:therapeutic use*; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000627:therapeutic use*; D006801:Humans; D007167:Immunotherapy; D007377:Interleukin-3 / Q000627:therapeutic use; D007891:Leishmania / Q000276:immunology; D007896:Leishmaniasis / Q000628:therapy*; D007963:Leukocytes, Mononuclear / Q000276:immunology / Q000469:parasitology; D016173:Macrophage Colony-Stimulating Factor / Q000627:therapeutic use; D008264:Macrophages / Q000276:immunology / Q000469:parasitology; D051379:Mice; D008807:Mice, Inbred BALB C; D011994:Recombinant Proteins / Q000276:immunology / Q000627:therapeutic use; D013154:Spleen / Q000166:cytology / Q000276:immunology; D014349:Trypanosoma cruzi / Q000276:immunology
D003115:Colony-Stimulating Factors; D007377:Interleukin-3; D011994:Recombinant Proteins; D016173:Macrophage Colony-Stimulating Factor; D016178:Granulocyte-Macrophage Colony-Stimulating Factor